Sign In
14 Jul 2010 15:05
Wednesday 14 July 2010
Cyprotex PLC
("Cyprotex" or the "Company")
Results of Annual General Meeting
At the Annual General Meeting of Cyprotex (AIM:CRX), the drug discovery technology and information company, held today all resolutions were passed.
Copies of the approved resolutions will be submitted to the UK Listing Authority and will shortly be available for inspection at the UK Listing Authority's Document Viewing Facility, which is situated at:
Financial Services Authority
25 The North Colonnade
Canary Wharf
London E14 5HS
Tel: +44 (0) 20 7676 1000
For further information:
|
Cyprotex PLC |
Tel: +44 (0) 1625 505 100 |
|
|
Dr Anthony Baxter, Chief Executive Officer John Dootson, Chief Financial Officer |
|
|
|
ir@cyprotex.com |
www.cyprotex.com |
|
|
|
|
|
|
Singer Capital Markets Ltd |
Tel: +44 203 205 7500 |
|
|
Shaun Dobson |
|
|
|
Claes Spång |
www.singercm.com |
|
|
|
|
|
|
Financial Dynamics |
Tel: +44 (0) 20 7831 3113 |
|
|
Ben Brewerton / Ben Atwell / Mo Noonan |
|
|
|
cyprotex@fd.com |
www.fd.com |
|
CRX.L (CRX)
Follow the stocks
